Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Understanding Vape Counter-Marketing Study

9 novembre 2026 aggiornato da: Shivani Gaiha, Boston Children's Hospital

Countering E-Cigarette Marketing in the Retail Environment Among Adolescents and Young Adults

The goal of this interventional study is to test whether short videos of electronic-cigarette (e-cigarette) counter-marketing lessons work to decrease people's intent to use and smoke e-cigarettes. Using short videos, the investigators hope to inform participants about the marketing strategies that e-cigarette companies use to try to get people to purchase and use e-cigarettes. The investigators hope to find that, after watching the short videos, people will be able to point out when e-cigarette companies are trying to sell their products, and hopefully they will have a lower interest in buying and using e-cigarettes. The investigators also hope participants will learn more about the addictiveness and harmfulness of using e-cigarettes by watching the short videos.

Panoramica dello studio

Tipo di studio

Interventistico

Iscrizione (Stimato)

2556

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Backup dei contatti dello studio

Luoghi di studio

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

Da 13 anni a 21 anni (Bambino, Adulto)

Accetta volontari sani

Sì

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

  • 13-21 years old
  • Fluent in English
  • Owns a smartphone or other device that can be used to complete study activities (e.g., watching videos, responding to electronic surveys)
  • Meets sampling ratio to match the US Census for sex assigned at birth, race, and ethnicity

Exclusion Criteria:

  • Fails survey validation checks (e.g., completing the survey too quickly, providing the same answer to every question)

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Prevenzione
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Separare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: New Intervention Group

Participants in this arm will receive a novel intervention developed by the study team.

Participants will view 4 short-form videos filmed by influencers. Influencers convey messaging designed to counter e-cigarette marketing in retail stores.

Comparatore attivo: Pre-existing Intervention

Participants will receive a comparable, pre-existing intervention not developed by the study team.

Participants will view 1 video in the public domain with messaging on e-cigarette marketing tactics.

Altro: Control Condition

Participants will receive a control condition that was not developed by the study team.

Participants will view 4 short-form influencer-generated videos on topics that are unrelated to counter e-cigarette marketing in retail stores.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Susceptibility to use e-cigarettes among those who never used
Lasso di tempo: From Day 1 (Baseline/Pre-intervention) to Day 31 (One-month follow-up after the treatment).

Susceptibility to use e-cigarettes among those who never used [Susceptibility scores are calculated based on the following 4 items:

  1. Do you think you will try/ use a nicotine vape in the next year?
  2. Do you think that you will try/use a nicotine vape soon?
  3. If one of your best friends were to offer you a nicotine vape, would you try/use it?
  4. Have you ever been curious about trying/using a nicotine vape? Response options for the first three items are: 1 = definitely not, 2 = probably not, 3 = probably yes, and 4 = definitely yes, and for the fourth item were: 1 = not at all curious, 2 = a little curious, 3 = somewhat curious, and 4 = very curious. Per Persoskie and O'Brien (2022), the four items are averaged to create a single index.]

O'Brien EK, Baig SA, Persoskie A. Developing and Validating Measures of Absolute and Relative E-Cigarette Product Risk Perceptions: Single Items Can Be Surprisingly Comprehensive. Nicotine Tob Res. 2022;24(3):316-323. doi:10.1093/ntr/n

From Day 1 (Baseline/Pre-intervention) to Day 31 (One-month follow-up after the treatment).

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
E-cigarette Use
Lasso di tempo: From Day 1 (Baseline/Pre-intervention) to Day 31 (One-month follow-up after the treatment).
  1. Have you EVER used any of the following products, even one or two puffs

  2. During the PAST 30 DAYS, have you used any of the following products, even one or two puffs?

  3. During the PAST 30 DAYS, on how many days (from 0 days to 30 days) did you use a… (numeric response)

  4. During the PAST 7 DAYS, have you used any of the following products, even one or two puffs?

  5. During the PAST 7 DAYS, on how many days (from 0 days to 7 days) did you use a…

  6. Other questions on age at first use, friend use and family use. All questions relate to the following products:

    • Nicotine vape
    • Some kind of vape (Don't know what was in it)
    • Cigarette
    • Nicotine pouch
From Day 1 (Baseline/Pre-intervention) to Day 31 (One-month follow-up after the treatment).
Intent to use e-cigarettes and cigarettes
Lasso di tempo: From Day 1 (Baseline/Pre-intervention); Day 1 (Immediately Post-intervention); and Day 31 (One-month follow-up after the treatment)

Do participants plan to use e-cigarettes and cigarettes?

From Day 1 (Baseline/Pre-intervention); Day 1 (Immediately Post-intervention); and Day 31 (One-month follow-up after the treatment)
Vaping attitudes and norms
Lasso di tempo: From Day 1 (Baseline/Pre-intervention); Day 1 (Immediately Post-intervention); and Day 31 (One-month follow-up after the treatment)

We will measure people's attitudes and acceptance towards vaping using: Vaping Attitudes Scale (5-point Likert-type; high score: positive attitude) and Mean Vaping Injunctive Norms Scale (3-item)

From Day 1 (Baseline/Pre-intervention); Day 1 (Immediately Post-intervention); and Day 31 (One-month follow-up after the treatment)
Pro-vaping marketing exposure (focused on retail), including marketing receptivity
Lasso di tempo: From Day 1 (Baseline/Pre-intervention) Day 31 (One-month follow-up after the treatment)

Can people understand and recognize e-cigarette marketing? Does it have an effect on them?

From Day 1 (Baseline/Pre-intervention) Day 31 (One-month follow-up after the treatment)
Marketing exposure on social media
Lasso di tempo: Day 1 (Baseline/Pre-intervention)

Questions to assess social media use, frequency, and platforms.

Day 1 (Baseline/Pre-intervention)
Anti-vaping content exposure
Lasso di tempo: Day 1 (Baseline/Pre-intervention)

Prior exposure to having seen content that dissuades people from using vapes and locations where they saw it.

Day 1 (Baseline/Pre-intervention)
Knowledge of e-cigarette retail marketing
Lasso di tempo: From Day 1 (Baseline/Pre-intervention); Day 1 (Immediately Post-intervention); and Day 31 (One-month follow-up after the treatment)

How much do people know about e-cigarette retail marketing (based on key messages and facts shown in video content)?

From Day 1 (Baseline/Pre-intervention); Day 1 (Immediately Post-intervention); and Day 31 (One-month follow-up after the treatment)
Perceived message effectiveness
Lasso di tempo: Day 1 (Immediately post-intervention)

We will test the effectiveness of the videos using two scales, the Message Assessment Scale for Tobacco Prevention Campaigns, and the Perceived Message Effectiveness Scale (6-item).

Day 1 (Immediately post-intervention)
Video acceptability
Lasso di tempo: Day 1 (Immediately post-treatment)

We will test how much people enjoyed and connected with the videos based on a quality rating scale and a question on alternative ways to receive content.

Day 1 (Immediately post-treatment)

Altre misure di risultato

Misura del risultato
Misura Descrizione
Lasso di tempo
Recruitment, enrollment, and attrition
Lasso di tempo: From Day 1 (Baseline/Pre-intervention); Day 1 (Immediately Post-intervention); and Day 31 (One-month follow-up after the treatment)

We want to measure recruitment and enrollment success, and how many people complete the study.

From Day 1 (Baseline/Pre-intervention); Day 1 (Immediately Post-intervention); and Day 31 (One-month follow-up after the treatment)
Video feasibility
Lasso di tempo: Day 1 (Immediately post-intervention)

We want to test whether people were able to watch the videos, how many of them they watched and for how long, and what devices they used to watch them.

Day 1 (Immediately post-intervention)

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

15 novembre 2026

Completamento primario (Stimato)

30 aprile 2027

Completamento dello studio (Stimato)

30 aprile 2027

Date di iscrizione allo studio

Primo inviato

3 novembre 2026

Primo inviato che soddisfa i criteri di controllo qualità

9 novembre 2026

Primo Inserito (Effettivo)

13 novembre 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

13 novembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

9 novembre 2026

Ultimo verificato

1 novembre 2026

Maggiori informazioni

Termini relativi a questo studio

Termini MeSH pertinenti aggiuntivi

Altri numeri di identificazione dello studio

  • 26-504
  • R00CA267477 (Sovvenzione/contratto NIH degli Stati Uniti)

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi